| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
GB:SBRE
Sabre Insurance Group plc
|
May 21, 2026 | HOLD |
Buy
-1.7% avg upside
6 analysts
|
$152.00
17.23% Downside
|
· |
|
GB:HSX
Hiscox
|
May 07, 2026 | SELL |
Strong Buy
+275.0% avg upside
15 analysts
|
$1148.00
37.91% Downside
|
· |
|
GB:AV
Aviva plc
|
May 03, 2026 | HOLD |
Buy
-2.4% avg upside
17 analysts
|
$637.00
2.87% Downside
|
· |
|
GB:LGEN
Legal & General
|
May 03, 2026 | SELL |
Buy
+497.1% avg upside
16 analysts
|
$185.00
36.08% Downside
|
· |
|
GB:LRE
Lancashire Holdings
|
Apr 30, 2026 | BUY |
Sell
+520.8% avg upside
12 analysts
|
$698.00
8.14% Upside
|
· |
|
GB:ADM
Admiral
|
Mar 09, 2026 | BUY |
Hold
-12.1% avg upside
14 analysts
|
$3770.00
4.42% Upside
|
· |
|
GB:CRE
Conduit Holdings Ltd
|
Feb 19, 2026 | BUY |
Buy
+13.7% avg upside
6 analysts
|
$427.00
2.07% Downside
|
· |
|
GB:0HAG
Sampo Plc
|
Feb 11, 2026 | HOLD |
Strong Buy
+113.3% avg upside
13 analysts
|
$10.20
6.10% Upside
|
· |
|
GB:BEZ
Beazley
|
Feb 05, 2026 | HOLD |
Strong Buy
+154.9% avg upside
14 analysts
|
$1310.00
1.68% Upside
|
· |
|
GB:0OJC
Gjensidige Forsikring ASA
|
Feb 05, 2026 | BUY |
Hold
-11.7% avg upside
10 analysts
|
$311.00
14.79% Upside
|
· |
|
GB:0R78
Tryg A/S
|
Sep 29, 2025 | HOLD |
Buy
+10.3% avg upside
9 analysts
|
$169.00
9.54% Upside
|
· |
|
DE:HNR1
Hannover Rueck
|
May 19, 2025 | BUY |
Buy
+5.7% avg upside
16 analysts
|
$309.00
22.62% Upside
|
· |
|
DE:MUV2
Munich Reinsurance
|
Mar 20, 2025 | HOLD |
Buy
-5.2% avg upside
17 analysts
|
$559.00
9.65% Upside
|
· |
|
FR:SCR
SCOR
|
Mar 06, 2025 | BUY |
Buy
-1.9% avg upside
12 analysts
|
$31.00
3.73% Downside
|
· |
|
CH:SREN
Swiss Re AG
|
Mar 03, 2025 | HOLD |
Hold
-9.3% avg upside
15 analysts
|
$156.00
15.93% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.